卡德萊蒂斯公司
DE ˙ DB ˙ US14161W1053
€0.49 ↓ -0.01 (-2.80%)
2026-06-04
分享價格
SecurityDE:CYX / Cardlytics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership626 shares
Latest Disclosed Value $ 657
Morgan Stanley reports 83.20% decrease in ownership of CYX / Cardlytics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 626 shares of Cardlytics, Inc. (DE:CYX) valued at $464 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 3,727 shares of Cardlytics, Inc.. This represents a change in shares of -83.20% during the quarter. The current value of the position is $304 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CARDLYTICS COM 14161W105 626 -3,101 -83.20 1 -100.00 0.0000
2026-05-27 2025-12-31 13F/A-1 CARDLYTICS COM 14161W105 3,727 -484,393 -99.24 4 -99.66 0.0000
2026-02-13 2025-12-31 13F CARDLYTICS COM 14161W105 3,727 -484,393 4 0.0000
2026-05-27 2025-09-30 13F/A-1 CARDLYTICS COM 14161W105 488,120 162,663 49.98 1,186 121.68 0.0001
2025-11-14 2025-09-30 13F CARDLYTICS COM 14161W105 488,120 162,663 1,186 0.0001
2025-08-15 2025-06-30 13F CARDLYTICS COM 14161W105 325,457 35,897 12.40 535 1.52 0.0000
2025-05-15 2025-03-31 13F CARDLYTICS COM 14161W105 289,560 -100,221 -25.71 527 -63.55 0.0000
2025-05-15 2024-12-31 13F/A-1 CARDLYTICS COM 14161W105 389,781 33,658 9.45 1,446 26.95 0.0001
2025-02-14 2024-12-31 13F CARDLYTICS COM 14161W105 389,781 33,658 1,446 0.0001
2025-05-14 2024-09-30 13F/A-2 CARDLYTICS COM 14161W105 356,123 -1,809,809 -83.56 1,140 -93.59 0.0001
2025-02-14 2024-09-30 13F/A-1 CARDLYTICS COM 14161W105 356,123 -1,809,809 1,140 0.0001
2024-11-14 2024-09-30 13F CARDLYTICS COM 14161W105 356,123 -1,809,809 1,140 0.0000
2025-05-14 2024-06-30 13F/A-2 CARDLYTICS COM 14161W105 2,165,932 -123,808 -5.41 17,782 -46.40 0.0014
2024-10-17 2024-06-30 13F/A-1 CARDLYTICS COM 14161W105 2,165,932 -123,808 17,782 0.0014
2024-08-14 2024-06-30 13F CARDLYTICS COM 14161W105 2,165,932 -123,808 17,782 0.0014
2024-10-17 2024-03-31 13F/A-2 CARDLYTICS COM 14161W105 2,289,740 1,176,720 105.72 33,178 223.69 0.0027
2024-08-16 2024-03-31 13F/A-1 CARDLYTICS COM 14161W105 2,289,740 1,176,720 33,178 0.0003
2024-05-15 2024-03-31 13F CARDLYTICS COM 14161W105 2,289,740 1,176,720 33,178 0.0027
2024-08-16 2023-12-31 13F/A-1 CARDLYTICS COM 14161W105 1,113,020 391,479 54.26 10,251 -13.90 0.0009
2024-02-13 2023-12-31 13F CARDLYTICS COM 14161W105 1,113,020 391,479 10,251 0.0009
2023-11-15 2023-09-30 13F CARDLYTICS COM 14161W105 721,541 361,283 100.28 11,905 423.07 0.0012
2023-08-14 2023-06-30 13F CARDLYTICS COM 14161W105 360,258 -45,770 -11.27 2,277 65.17 0.0002
2023-05-15 2023-03-31 13F CARDLYTICS COM 14161W105 406,028 -64,107 -13.64 1,378 -49.28 0.0001
2023-02-14 2022-12-31 13F CARDLYTICS COM 14161W105 470,135 252,346 115.87 2,717 32.73 0.0003
2022-11-14 2022-09-30 13F CARDLYTICS COM 14161W105 217,789 -455,181 -67.64 2,047 -86.37 0.0003
2022-10-27 2022-06-30 13F/A-1 CARDLYTICS COM 14161W105 672,970 -97,483 -12.65 15,014 -64.56 0.0019
2022-08-15 2022-06-30 13F CARDLYTICS COM 14161W105 672,970 -97,483 15,014 0.0019
2022-10-27 2022-03-31 13F/A-1 CARDLYTICS COM 14161W105 770,453 -173,874 -18.41 42,360 -32.13 0.0057
2022-05-13 2022-03-31 13F CARDLYTICS COM 14161W105 770,453 -173,874 42,360 0.0057
2022-02-14 2021-12-31 13F CARDLYTICS COM 14161W105 944,327 9,768 1.05 62,411 -20.44 0.0077
2021-11-15 2021-09-30 13F CARDLYTICS COM 14161W105 934,559 181,266 24.06 78,446 -17.96 0.0106
2021-08-23 2021-06-30 13F/A-1 CARDLYTICS COM 14161W105 753,293 -280,762 -27.15 95,616 -15.71 0.0126
2021-08-16 2021-06-30 13F CARDLYTICS COM 14161W105 753,293 -280,762 95,616 0.0026
2021-05-17 2021-03-31 13F CARDLYTICS COM 14161W105 1,034,055 211,201 25.67 113,436 -3.44 0.0167
2021-02-16 2020-12-31 13F CARDLYTICS COM 14161W105 822,854 -39,679 -4.60 117,479 93.00 0.0181
2020-11-13 2020-09-30 13F CARDLYTICS COM 14161W105 862,533 99,352 13.02 60,869 13.97 0.0118
2020-08-14 2020-06-30 13F CARDLYTICS COM 14161W105 763,181 454,705 147.40 53,407 395.20 0.0118
2020-05-26 2020-03-31 13F/A-1 CARDLYTICS COM 14161W105 308,476 -97,158 -23.95 10,785 -57.70 0.0029
2020-05-15 2020-03-31 13F CARDLYTICS COM 14161W105 308,476 -97,158 10,785 828.5128
2020-02-14 2019-12-31 13F CARDLYTICS COM 14161W105 405,634 173,860 75.01 25,499 228.21 0.0059
2019-11-14 2019-09-30 13F CARDLYTICS COM 14161W105 231,774 218,597 1,658.93 7,769 2,171.64 0.0021
2019-08-14 2019-06-30 13F CARDLYTICS COM 14161W105 13,177 11,645 760.12 342 1,268.00 0.0001
2019-05-15 2019-03-31 13F CARDLYTICS COM 14161W105 1,532 -30,554 -95.23 25 -92.82 0.0000
2019-02-14 2018-12-31 13F CARDLYTICS COM 14161W105 32,086 16,193 101.89 348 -12.56 0.0001
2019-04-23 2018-09-30 13F/A-2 CARDLYTICS COM 14161W105 15,893 3,357 26.78 398 45.79 0.0001
2018-11-20 2018-09-30 13F/A-1 CARDLYTICS COM 14161W105 15,893 0 398 0.0001
2018-11-14 2018-09-30 13F CARDLYTICS COM 14161W105 15,893 3,357 398
2019-04-23 2018-06-30 13F/A-1 CARDLYTICS COM 14161W105 12,536 658 5.54 273 56.90 0.0001
2018-08-14 2018-06-30 13F CARDLYTICS COM 14161W105 12,536 658 273
2019-04-23 2018-03-31 13F/A-1 CARDLYTICS COM 14161W105 11,878 11,878 174 0.0000
2018-05-14 2018-03-31 13F CARDLYTICS COM 14161W105 11,878 174 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.